J.Molner AS (OTSE:MOLNR) Debt-to-EBITDA : -2.10 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

J.Molner AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.27 Mil. J.Molner AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €1.91 Mil. J.Molner AS's annualized EBITDA for the quarter that ended in Dec. 2023 was €-1.04 Mil. J.Molner AS's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -2.10.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for J.Molner AS's Debt-to-EBITDA or its related term are showing as below:

OTSE:MOLNR' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.43 Med: -2.42 Max: -2.04
Current: -2.43

During the past 3 years, the highest Debt-to-EBITDA Ratio of J.Molner AS was -2.04. The lowest was -2.43. And the median was -2.42.

OTSE:MOLNR's Debt-to-EBITDA is ranked worse than
100% of 661 companies
in the Drug Manufacturers industry
Industry Median: 1.69 vs OTSE:MOLNR: -2.43

J.Molner AS Debt-to-EBITDA Historical Data

The historical data trend for J.Molner AS's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Debt-to-EBITDA Chart

J.Molner AS Annual Data

Trend

Dec21

Dec22

Dec23

Debt-to-EBITDA

-2.04

-2.42

-2.43

J.Molner AS Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-EBITDA	N/A	-0.92	-2.06	-1.60	-2.10

Competitive Comparison of J.Molner AS's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, J.Molner AS's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

J.Molner AS's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, J.Molner AS's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where J.Molner AS's Debt-to-EBITDA falls into.

J.Molner AS Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

J.Molner AS's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.268	+	1.911)	/	-0.896
	=	-2.43

J.Molner AS's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.268	+	1.911)	/	-1.036
	=	-2.10

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.

J.Molner AS (OTSE:MOLNR) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

J.Molner AS Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

J.Molner AS (OTSE:MOLNR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Debt-to-EBITDA

Traded in Other Exchanges

N/A

Address

Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618

Website

https://www.jmolner.com

J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines